Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Acta Pharmaceutica Sinica. B|September 2, 2024
CCL9/CCR1 axis-driven chemotactic nanovesicles for attenuating metastasis of SMAD4-deficient colorectal cancer by trapping TGF-<i>β</i>Boning Niu, Tianyi Tian, Lu Wang, et al.ACS Applied Materials & Interfaces|June 30, 2022
Yeast Microcapsule Mediated Natural Products Delivery for Treating Ulcerative Colitis through Anti-Inflammatory and Regulation of Macrophage PolarizationXingxing Feng, Qi Xie, Hongbo Xu, et al.Advanced Healthcare Materials|November 19, 2022
Boosting B Cell and Macrophage-Mediated Humoral Immunity with Fusion Nanovesicles for Triple-Negative Breast Cancer Combined TherapyYulin Yu, Yang Li, Yinmei Tian, et al.Small (Weinheim an Der Bergstrasse, Germany)|April 5, 2024
Colon Targeting pH-Responsive Coacervate Microdroplets for Treatment of Ulcerative ColitisYinmei Tian, Qian Hu, Zhengjun Sun, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|November 22, 2023
Biofunctional coacervate-based artificial protocells with membrane-like and cytoplasm-like structures for the treatment of persistent hyperuricemiaQian Hu, Hongbing Lan, Yinmei Tian, et al.Advanced Healthcare Materials|July 25, 2024
Mitoxantrone Combined with Engineered TRAIL-Nanovesicles for Enhanced Cancer Immunotherapy Via Converting Apoptosis into PyroptosisYi Wang, Boning Niu, Yinmei Tian, et al.ACS Nano|January 3, 2024
Engineered Biomimetic Nanovesicles Based on Neutrophils for Hierarchical Targeting Therapy of Acute Respiratory Distress SyndromeXiaonan Li, Qi Qiao, Xiong Liu, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|March 23, 2025
Engineered vesicular cancer vaccines for immunosuppressive microenvironment reversion and in situ vaccine generationYang Li, Yulin Yu, Bin Xia, et al.Pageof 1